Injection Drug Use-Associated HIV, HCV Risk Higher in Women, Younger Individuals
Researchers evaluated global data on HIV infection and primary hepatic C virus infection incidence among injections drug users.
Researchers evaluated global data on HIV infection and primary hepatic C virus infection incidence among injections drug users.
Nonalcoholic fatty liver disease and alcoholic liver disease are underrecognized causes of osteoporosis in men.
Researchers compared hepatitis C virus point-of-care RNA viral load testing with laboratory-based testing to determine the effects on treatment uptake and turnaround times.
Researchers evaluated whether HIV DNA persists in the liver among individuals receiving suppressive antiretroviral therapy.
Liver disease and cirrhosis now outpace diabetes and stroke as the leading cause of mortality in people aged 25 to 54 years. New survey results shows shortfalls in adoption of national treatment guidelines for liver disease and cirrhosis.
Among persons who inject drugs with chronic HCV infection, proportion with detectable HCV RNA decreased from 100% in 2006 to 48% in 2019.
No increase in acute hepatitis of unspecified etiology, adenovirus types 40/41 above prepandemic baseline levels.
Pharmacotherapy for alcohol use disorder linked to reduced incidence of hepatic decompensation in patients with cirrhosis.
In this study, researchers assessed the nationwide rate of testing and treatment initiations for hepatitis C virus infection in the United States following the onset of the COVID-19 pandemic through the end of 2020.
Investigators assessed the manufacturing consistency, safety, and efficacy of a 3-antigen hepatitis B vaccine vs a single-antigen formulation.